Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05594251 · ClinicalTrials.gov registry record

Early Detection of Endotheliopathy Post-Transplant

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Terminated
Registry status
32
Enrollment target

NCT05594251: Clinical Trial study, sponsored by St. Jude Children's Research Hospital.

NCT05594251 is a clinical trial that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05594251 was terminated before completion, sponsored by St. Jude Children's Research Hospital.

TERMINATED
Registry status
32 participants
Enrollment target

Study Summary

The goal of this research study is to learn more about possible risk factors that might be associated with side effects from stem cell transplants in people between the ages of 0 to 26 years old. Specifically, this study is looking at complications that arise from injury to the endothelium, a small layer of cells lining the blood vessels and heart. These complications can affect the heart, lungs, liver, kidneys and intestines and increase risk of severe illness needing care in the intensive care unit.

Primary Outcome

The proportion of pediatric patients undergoing HCT who develop critical illness (defined by admission to the pediatric intensive care unit at St. Jude for reasons other than observation after procedure) will be estimated using one-sample binomial estimates and various confidence intervals.

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-11-28
Est. Completion 2024-05-05

Why NCT05594251 stopped before completion

NCT05594251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT05594251 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05594251 about?

NCT05594251 is a clinical study titled "Early Detection of Endotheliopathy Post-Transplant". The goal of this research study is to learn more about possible risk factors that might be associated with side effects from stem cell transplants in people between the ages of 0 to 26 years old. Specifically, this study is looking at complications that arise from injury to the endothelium, a small ...

What is the current status of trial NCT05594251?

This trial is currently terminated. The enrollment target is 32 participants. The study started on 2022-11-28. Estimated completion is 2024-05-05.

Who is sponsoring clinical trial NCT05594251?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05594251, the US trial registry maintained by the National Library of Medicine. NCT05594251 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.